首页> 外文OA文献 >Novel methods to incorporate photosensitizers into nanocarriers for cancer treatment by photodynamic therapy
【2h】

Novel methods to incorporate photosensitizers into nanocarriers for cancer treatment by photodynamic therapy

机译:通过光动力疗法将光敏剂结合到纳米载体中用于癌症治疗的新方法

代理获取
本网站仅为用户提供外文OA文献查询和代理获取服务,本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文,但由于OA文献来源多样且变更频繁,仍可能出现获取不到、文献不完整或与标题不符等情况,如果获取不到我们将提供退款服务。请知悉。

摘要

Objective A hydrophobic photosensitizer, 2‐[1‐hexyloxyethyl]‐2‐devinyl pyropheophorbide‐a (HPPH), was loaded into nontoxic biodegradable amine functionalized polyacrylamide (AFPAA) nanoparticles using three different methods (encapsulation, conjugation, and post‐loading), forming a stable aqueous dispersion. Each formulation was characterized for physicochemical properties as well as for photodynamic performance so as to determine the most effective nanocarrier formulation containing HPPH for photodynamic therapy (PDT). Materials and Methods HPPH or HPPH‐linked acrylamide was added into monomer mixture and polymerized in a microemulsion for encapsulation and conjugation, respectively. For post‐loading, HPPH was added to an aqueous suspension of pre‐formed nanoparticles. Those nanoparticles were tested for optical characteristics, dye loading, dye leaching, particle size, singlet oxygen production, dark toxicity, in vitro photodynamic cell killing, whole body fluorescence imaging and in vivo PDT. Results HPPH was successfully encapsulated, conjugated or post‐loaded into the AFPAA nanoparticles. The resultant nanoparticles were spherical with a mean diameter of 29 ± 3 nm. The HPPH remained intact after entrapment and the HPPH leaching out of nanoparticles was negligible for all three formulations. The highest singlet oxygen production was achieved by the post‐loaded formulation, which caused the highest phototoxicity in in vitro assays. No dark toxicity was observed. Post‐loaded HPPH AFPAA nanoparticles were localized to tumors in a mouse colon carcinoma model, enabling fluorescence imaging, and producing a similar photodynamic tumor response to that of free HPPH in equivalent dose. Conclusions Post‐loading is the promising method for loading nanoparticles with hydrophobic photosensitizers to achieve effective in vitro and in vivo PDT. Lasers Surg. Med. 43:686–695, 2011. © 2011 Wiley‐Liss, Inc.
机译:目的使用三种不同的方法(包封,缀合和后加载)将疏水性光敏剂2- [1- [己氧基基乙基] -2-癸二酮基焦脱镁叶绿酸-a(HPPH)装入无毒的可生物降解的胺官能化聚丙烯酰胺(AFPAA)纳米颗粒中,形成稳定的水分散体。对每种制剂的理化性质和光动力性能进行表征,以便确定最有效的包含HPPH的纳米载体制剂用于光动力疗法(PDT)。材料和方法将HPPH或HPPH连接的丙烯酰胺添加到单体混合物中,并在微乳液中进行聚合,分别用于包封和偶联。对于后加载,将HPPH添加到预先形成的纳米颗粒的水悬浮液中。测试了这些纳米颗粒的光学特性,染料负载,染料浸出,粒径,单线态氧产生,暗毒性,体外光动力细胞杀伤,全身荧光成像和体内PDT。结果HPPH已成功封装,偶联或后装载到AFPAA纳米颗粒中。所得的纳米颗粒为球形,平均直径为29±3 nm。包封后,HPPH保持完整,而对于所有三种制剂,从纳米颗粒中浸出的HPPH可以忽略不计。后装制剂实现了最高的单线态氧产量,这在体外测定中引起了最高的光毒性。没有观察到暗毒性。加载后的HPPH AFPAA纳米颗粒位于小鼠结肠癌模型中的肿瘤上,能够进行荧光成像,并产生与游离HPPH等效剂量的相似的光动力肿瘤反应。结论后加载是用疏水性光敏剂加载纳米粒子以实现有效的体外和体内PDT的有前途的方法。激光手术。中43:686–695,2011.©2011 Wiley‐Liss,Inc.

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
代理获取

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号